SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-013389
Filing Date
2020-03-27
Accepted
2020-03-27 08:10:15
Documents
5
Effectiveness Date
2020-03-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A torc-defa14a_20200506.htm DEFA14A 31500
2 GRAPHIC g0br21if44iv000003.jpg GRAPHIC 15386
3 GRAPHIC g0br21if44iv000004.jpg GRAPHIC 8171
4 GRAPHIC g0br21if44iv000002.jpg GRAPHIC 68381
5 GRAPHIC g0br21if44iv000001.jpg GRAPHIC 41696
  Complete submission text file 0001564590-20-013389.txt   217112
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38359 | Film No.: 20748093
SIC: 2834 Pharmaceutical Preparations